TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Reported diluted earnings per share of $0.21 Mutual fund gross sales of $790 million for the third quarter
Helsinn Group and BridgeBio Pharma’s Affiliate QED Therapeutics Announce Health Canada Conditional Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma – Health Canada Issues Conditional
WM’s ICLM and TUV Unitary Global Payments Systems provide a fully operational and benign model for a functioning Cashless Society worldwide NEW YORK and ST
ADG20 Continues to be Well Tolerated in Healthy Volunteers with Prolonged Half-Life and Serum Virus Neutralization Activity Observed out to Six Months in Ongoing Phase
Philogen Provides Corporate Update Nidlegy™ and Fibromun on track with planned timelines in pivotal clinical trials Use of Nidlegy™ in non-melanoma skin cancer expanded in
The Distinguished Gentleman’s Drive attracts thousands of vintage automotive enthusiasts in its first-ever global charity drive, raising $200,000 for men’s mental health and prostate cancer
“Conscience is like a beautiful and fragrant flower. When in blossom, the fragrance will enliven the world and be smelled by all.” ~ Dr. Hong,
Phoenix Software released updates to its product line in September 2021 EL SEGUNDO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Phoenix Software International, Inc., today